Showing 1 - 20 results of 41 for search 'Azzariti, Amalia', query time: 0.20s Refine Results
The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma
Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects

The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review

Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position

The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line
microRNAs and next generation sequencing for the prognosis of the metastatic melanoma

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response
Frizzled-10 and cancer progression: Is it a new prognostic marker?

The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives
Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation

New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity
Antitumor Potential of Conjugable Valinomycins Bearing Hydroxyl Sites: In Vitro Studies

Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach
Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
Grape seed extracts modify the outcome of oxaliplatin in colon cancer cells by interfering with cellular mechanisms of drug cytotoxicity

Search Tools: Get RSS Feed — Email this Search — Save Search